Mirati Therapeutics logo
Mirati Therapeutics MRTX
$ 58.7 0.0%

Quarterly report 2023-Q3
added 11-06-2023

report update icon

Mirati Therapeutics Deferred Revenue 2011-2024 | MRTX

Annual Deferred Revenue Mirati Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 824 K 371 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
824 K 371 K 598 K

Quarterly Deferred Revenue Mirati Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - 65 M - - - - - 824 K - - 638 K 371 K 439 K 318 K 371 K - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
65 M 318 K 9.71 M